2-tert-butylhydroquinone has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alleyne, CH; Dhandapani, KM; Prasad, N; Sukumari-Ramesh, S; Vender, JR | 1 |
| Honey, CR; Johnson, DA; Johnson, JA; Murphy, TH; Ng, R; Shen, H; Yu, J | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and Glioma
| Article | Year |
|---|---|
Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells.
Topics: Antineoplastic Agents, Alkylating; Antioxidants; Carmustine; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression; Glioma; Humans; Hydroquinones; NF-E2-Related Factor 2; Oxidative Stress; Up-Regulation | 2015 |
Preferential expression of antioxidant response element mediated gene expression in astrocytes.
Topics: Animals; Antioxidants; Astrocytes; Base Sequence; Biolistics; Cells, Cultured; Cerebral Cortex; Dimethyl Fumarate; Fumarates; Gene Expression Regulation, Enzymologic; Genes, Reporter; Glioma; Glutamate-Cysteine Ligase; Glutathione Transferase; Humans; Hybridomas; Hydroquinones; In Vitro Techniques; Molecular Sequence Data; Neuroblastoma; Neuroglia; Promoter Regions, Genetic; Quinone Reductases; Rats; Recombinant Fusion Proteins; Transfection | 2001 |